arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

LifeMD, Inc.

LFMD Health Care Medical/Nursing Services
$3.14
▲ +1.9% Today
as of Sep 4, 16:51 ET
Last 30 days -19.79% Jul 28 → Sep 04
$2.98 $3.23 $3.48 $3.72 $3.97 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$3.03
High
$3.10
Low
$3.02
Volume
$604,650
Avg Vol
$1M
Mkt Cap
$167M
P/E (TTM)
—
Beta
—
52w High
$7.32
52w Low
$2.56
Div Yield
—
Shares Out
$48M

Recent Press Releases & News last 60 days · 10 items

Aug 23 · 05:09 Simply Wall St.
LifeMD (LFMD) Stock Sees Fair Value Cut After Analysts Lower Targets On Weaker Guidance
Aug 13 · 00:13 Motley Fool
LifeMD (LFMD) Q2 2026 Earnings Call Transcript
Aug 6 · 13:14 MT Newswires
B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating
▸ Show all 10 press releases & news Free account →

Overview

52-week range
$2.56
$7.32
12% of range
Avg surprise (last 3)
-39.3%
Avg reaction (last 2)
+2.8%
100% positive
Latest IV / EM
62%
EM ±9.7% · $3 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.20$-0.15$-0.10$-0.04$0.01 Actual $-0.13Actual $0.01Est $-0.04Actual $-0.06Est $-0.02Actual $-0.20Est $-0.14Actual $-0.16 SepMar/2025Jun/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-9M$9M$27M$45M$63M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.16 — — — — financials
Wed May 6, 2026Mar/2026 $-0.20 $-0.14 -42.9% -2,100% +2.7% earnings
Tue Aug 5, 2025Jun/2025 $-0.06 $-0.02 -200.0% — — earnings
Tue May 6, 2025Mar/2025 $0.01 $-0.04 +125.0% — +2.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.13 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$47M$50M—$60M$49M$51M—$53M
Cost of revenue$5M$6M—$7M$7M$8M—$5M
Gross profit$42M$44M—$53M$42M$43M—$48M
Operating income$-7M$-9M—$-2M$-2M$-1M—$-4M
Net income$-7M$-9M—$-4M$-2M$348,067—$-5M
EPS (diluted)$-0.16$-0.20——$-0.05$-0.02—$-0.13

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$25M$34M$37M$24M$36M$34M$35M$38M
Inventory$3M$3M$3M$3M$3M$3M$3M$3M
Total current assets$42M$52M$52M$41M$49M$50M$52M$49M
Total assets$60M$70M$70M$66M$74M$74M$76M$73M
Long-term debt————$16M———
Total liabilities$52M$55M$47M$63M$73M$74M$84M$79M
Total equity$8M$15M$23M$1M$-4M$-5M$-9M$-5M

Implied volatility — last 90 days

62%201%341%480%620% Jun 07 — IV 107% · EM ±14.8%Jun 08 — IV 104% · EM ±13.8%Jun 09 — IV 124% · EM ±15.6%Jun 10 — IV 94% · EM ±11.1%Jun 11 — IV 111% · EM ±12.2%Jun 12 — IV 125% · EM ±12.8%Jun 15 — IV 113% · EM ±8.1%Jun 16 — IV 114% · EM ±6.7%Jun 17 — IV 195% · EM ±8.1%Jun 19 — IV 102% · EM ±22.6%Jun 22 — IV 114% · EM ±23.8%Jun 23 — IV 113% · EM ±23.1%Jun 24 — IV 108% · EM ±21.7%Jun 25 — IV 95% · EM ±18.7%Jun 26 — IV 85% · EM ±16.3%Jun 29 — IV 91% · EM ±16.1%Jun 30 — IV 88% · EM ±15.1%Jul 01 — IV 115% · EM ±19.3%Jul 02 — IV 86% · EM ±13.9%Jul 03 — IV 89% · EM ±13.9%Jul 06 — IV 92% · EM ±12.7%Jul 07 — IV 93% · EM ±12.3%Jul 08 — IV 110% · EM ±13.8%Jul 09 — IV 89% · EM ±10.6%Jul 10 — IV 93% · EM ±10.2%Jul 13 — IV 119% · EM ±10.0%Jul 14 — IV 291% · EM ±21.1%Jul 15 — IV 355% · EM ±21.0%Jul 16 — IV 517% · EM ±21.6%Jul 20 — IV 96% · EM ±22.6%Jul 21 — IV 105% · EM ±24.4%Jul 22 — IV 96% · EM ±22.0%Jul 23 — IV 101% · EM ±22.6%Jul 24 — IV 107% · EM ±23.6%Jul 27 — IV 114% · EM ±23.9%Jul 28 — IV 115% · EM ±23.4%Jul 29 — IV 124% · EM ±24.9%Jul 30 — IV 119% · EM ±23.4%Jul 31 — IV 131% · EM ±25.0%Aug 03 — IV 140% · EM ±24.8%Aug 04 — IV 127% · EM ±21.8%Aug 05 — IV 158% · EM ±26.5%Aug 06 — IV 86% · EM ±13.9%Aug 07 — IV 126% · EM ±19.7%Aug 10 — IV 115% · EM ±15.9%Aug 11 — IV 258% · EM ±34.0%Aug 12 — IV 181% · EM ±22.7%Aug 13 — IV 237% · EM ±27.9%Aug 14 — IV 249% · EM ±27.5%Aug 17 — IV 288% · EM ±24.1%Aug 18 — IV 296% · EM ±21.4%Aug 19 — IV 373% · EM ±22.1%Aug 20 — IV 621% · EM ±25.9%Aug 24 — IV 69% · EM ±14.3%Aug 25 — IV 76% · EM ±15.6%Aug 26 — IV 70% · EM ±14.1%Aug 27 — IV 70% · EM ±13.8%Aug 28 — IV 75% · EM ±14.3%Aug 31 — IV 73% · EM ±12.9%Sep 01 — IV 70% · EM ±12.1%Sep 02 — IV 73% · EM ±12.2%Sep 03 — IV 66% · EM ±10.7%Sep 04 — IV 62% · EM ±9.7%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in